Cancer still tops high-cost health claims, but muscle and orthopedic conditions are making surprise surge

Sun Life, the nation's leading independent stop-loss provider for self-funded employers, released its 13th annual high-cost claim and injectable drugs trend analysis, examining more than 65,000 health claims from 3,000 employers between 2021 and 2024.